Answer
Darbepoetin alfa (Aranesp) has no adequate, well-controlled studies in pregnant women; animal studies indicate no direct harmful effects on pregnancy, embryonal/foetal development, birth or postnatal development, but caution is required when prescribing during pregnancy.
Sources for this answer
- Aranesp solution for injection in pre-filled syringe / Aranesp solution for injection in pre-filled syringe with needle guardAmgen Ltd · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 1Document updated
Sources checked